GlobeNewswire Inc.··DelveinsightPolycythemia Vera Market Poised for Major Expansion as Nine Pharma Giants Rush New Therapies
Polycythemia vera market expected to expand 8.9% CAGR through 2036 from $2B base as nine pharma companies advance novel therapies, with rusfertide entering first.
MRKPTGXIRONTAKIONS+1clinical trialsmarket expansion